which then potently suppressed inflammation in this mouse model of neutrophilic asthma. More information: Vijay Raaj Ravi et ...
New therapeutic "cocktails" could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of ...
The researchers demonstrated that they could treat a mouse model of severe allergic asthma using either a combination of an ICOSL and OX40L inhibitor—or an ICOSL and CD30L inhibitor. The ...
Medically reviewed by Daniel More, MD Managing your allergic asthma requires a comprehensive approach. There are no proven ...
Asthma is a heterogeneous disorder ... In conclusion, we demonstrate that TNFα reduces the responsiveness to GCs in a mouse model of neutrophilic airway inflammation. Thus antagonizing TNFα ...
A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical ...
Biologists refer to the mouse as a “model organism,” because they can ... Alzheimer’s disease, asthma, diabetes, heart disease and Parkinson’s disease. It started with a virus (a tale ...
Rapid resolution of systemic anaphylactic reaction in a therapeutic mouse model. Reduction of serum IgE and eosinophils in bronchoalveolar lavage (BAL) in rat allergen-induced asthma model.